Applicant, as named in the Orange Book
Collegium Pharm Inc
Next listed expiry: Nucynta on 3 Jan 2027. 3 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Nucynta · 3 strengths tapentadol hydrochloride | 3 Jan 2027 |
| Nucynta Er · 5 strengths tapentadol hydrochloride | 22 Mar 2029 |
| Xtampza Er · 5 strengths oxycodone | 2 Sep 2036 |
Recent events
- 25 Oct 2026Nucynta · Generic approved 10 Feb 2026
- 25 Oct 2026Nucynta · Generic approved 3 Sep 2026
- 25 Oct 2026Nucynta · First generic approved 26 Jan 2026
- 25 Oct 2026Nucynta · Generic approved 26 Jan 2026
- 25 Oct 2026Nucynta · First generic approved 27 Jan 2026
- 25 Oct 2026Nucynta · Generic approved 27 Jan 2026
- 24 Oct 2026Nucynta · Exclusivity expires within 90 days PED3 Jan 2027
- 24 Oct 2026Nucynta · Enters 12-month window basis: exclusivity3 Jan 2027
- 24 Oct 2026Nucynta · Exclusivity expires within 90 days PED3 Jan 2027
- 24 Oct 2026Nucynta · Enters 12-month window basis: exclusivity3 Jan 2027
- 24 Oct 2026Nucynta · Exclusivity expires within 90 days PED3 Jan 2027
- 24 Oct 2026Nucynta · Enters 12-month window basis: exclusivity3 Jan 2027
- 24 Oct 2026Nucynta · Exclusivity expires within 90 days PED3 Jan 2027
- 24 Oct 2026Nucynta · Enters 12-month window basis: exclusivity3 Jan 2027